Comparable efficacy and safety of bridging therapy versus direct mechanical thrombectomy in anterior circulation large vessel occlusion stroke

前循环大血管闭塞性卒中中,桥接治疗与直接机械取栓术的疗效和安全性相当

阅读:1

Abstract

OBJECTIVE: To compare the clinical and procedural outcomes, as well as complication rates, between bridging therapy (BT) and direct mechanical thrombectomy (D-MT) in patients with acute ischemic stroke (AIS) due to anterior circulation large vessel occlusion (LVO). METHODS: In this retrospective cohort study, 169 patients who underwent endovascular therapy (EVT) between January 2021 and January 2024 were included. Patients were divided into a BT group (n=96, intravenous alteplase followed by thrombectomy) and a D-MT group (n=73, thrombectomy alone). Baseline characteristics, procedural data, and 90-day functional outcomes were compared. Multivariable logistic regression identified predictors of 90-day favorable outcome (modified Rankin Scale score 0-2). RESULTS: Baseline characteristics were balanced between the groups (all P>0.05). The BT group showed a numerically higher rate of 90-day favorable functional outcome (56.25% vs. 46.58%, P=0.212) and lower mortality rate (4.17% vs. 10.96%, P=0.089), but differences were not statistically significant. Recanalization rates (modified Thrombolysis in Cerebral Infarction (mTICI) 2b/3: ~95%) and complication rates (hemorrhagic transformation, post-awakening stroke) were similar between the groups (all P>0.05). In regression analysis, smoking history, baseline National Institutes of Health Stroke Scale (NIHSS) score, and collateral circulation grade were independent predictors of outcome, while treatment modality was not. CONCLUSION: BT and D-MT demonstrate comparable efficacy and safety in treating anterior circulation LVO. The choice of strategy should consider patient-specific factors such as baseline neurological status and collateral circulation, rather than presumed superiority of either modality.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。